Thu 25 Jun 2026
All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.
All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.
| Study Title | Study Sponsor | Status | Study Drug | Trial Phase | Study Protocol Number | Site |
|---|---|---|---|---|---|---|
| Global Registry Program on Long-Term Oral Anti-thrombotic TReatment In PAtients with Atrial Fibrillation. | Boehringer Ingelheim | Ongoing | Dabigatran (dabigatran etexilate = prodrug) | 4 | 1160.129 | King Fahad Medical City (Riyadh), King Faisal Hospital (Taif) , King Salman Bin AbdulAziz Hospital (Riyadh), King Fahad Hospital (Hofuf), Armed Forces Hospital (Southern Region) , Armed Forces Hospital (North West Region) |
| Prevalence and Patient Experience with Condylomas Study in Saudi Arabia | Merck Serono | Ongoing | N/A | 4 | PREPEC | King Abdulaziz University Hospital (Jeddah), Prince Sultan Military Medical City (Riyadh) , King Fahad Medical City (Riyadh) |
| A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study | Eli Lilly | Ongoing | N/A | 4 | F3Z-MC-B010 | Al-Noor Specialist Hospital (Makkah), Armed Forces Hospital (Taif) , King Fahad Medical City (Riyadh) |
| Inhibitor Development in Previously Untreated Patients (PUPs) or Minimally Blood Component-Treated Patients (MBCTPs) When Exposed to Plasma-derived Von Willebrand Factor-Containing Factor VIII (VWF/FVIII) Concentrates and to Recombinant Factor VIII (rFVIII) Concentrates: An Independent, International, Multicentre, Prospective, Controlled, Randomised, Open Label, Clinical Trial) | King Faisal Specialist Hospital & Research Centere | Ongoing | PLASMA DERIVED Factor VIII Recombinant FVIII | 4 | ABB- 09 -001 | King Faisal Specialist Hospital and Research Center (Riyadh) |
| Registry on Monitoring the Effectiveness and Tolerability of Basal (Plus/Bolus) Regimen with LantusÒ (Insulin Glargine) and ApidraÒ (Insulin Glulisine) in T2 Diabetes Mellitus Patients in Everyday Practice in Saudi | Sanofi | Ongoing | Lantus® | 4 | LANTUL06939 | King Fahd Military Medical Complex (Dhahran), Armed Forces Hospital (Southern Region), Polyclinics in western province |
| An international, multicenter, observational study to compare real life VTE prophylaxis, during hospital stay, in cancer patients undergoing major abdominal or pelvic surgery versus international guidelines (ACCP 2008). | Sanofi | Ongoing | N/A | 4 | DIREG_R_04917 | King Faisal Specialist Hospital and Research Center (Jeddah) |
| National, observational, cross sectional survey evaluating the atrial fibrillation management and cardiovascular risk profile of AF patient. | Sanofi | Ongoing | N/A | 4 | DIREG_L_05290 | King Khalid University Hospital (Riyadh) |
| Disease pattern in patient with acute respiratory tract infections in Saudi Arabia | Sanofi | Ongoing | N/A | 4 | DIREG_L_05605 | Erfan & Bagedo General Hospital (Jeddah) |
| Superiority of Insulin Glargine Lantus vs. NPH: Treat to Normoglycemia Concept.Effect of Insulin Glargine in Comparison to Insulin NPH in Insulin-nave People With Type 2 Diabetes Mellitus Treated With at Least One OAD and Not Adequately Controlled | Sanofi | Ongoing | Lantus® | 4 | Lantu_C_02762 | King Abdulaziz University Hospital (Jeddah), King Fahad University Hospital (Al-Khobar) |
| Registry in the management of Acute Diarrhea in Children : Observational study in Daily practice | Sanofi | Ongoing | N/A | 4 | DIREG_R_06373 | King Fahad Medical City (Riyadh) |
Last update date: 08/05/2025 at 03:17 PM Saudi Arabia time
No feedback has been submitted for this page yet.
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.